Flebogamma® 10% DIF

Manufacturer: Grifols Biologicals, Inc.

Indications: Replacement therapy in primary (inherited) humoral immunodeficiency disorders, such as common variable immunodeficiency, x-linked agammaglobulinemia, severe combined immunodeficiency, and Wiskott-Aldrich Syndrome
Broad Safety Margin:
- Pasteurization
- olvent / Detergent
- 20 nm Nanofiltration
High purity 10 % concentration immune globulin
Trace amounts of IgA
Stabilized with sorbitol
Sucrose and maltose free
Very low sodium content
Liquid: Ready to use. No need for reconstitution
Dosing flexibility: 3 vial sizes available, including a 20 g vial